Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028584 · ClinicalTrials.gov registry record
Survivorship Care Plans in a Community Oncology Practice
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 30
- Enrollment target
NCT03028584: Completed study, sponsored by University of Wisconsin, Madison.
NCT03028584 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03028584 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a two part observational study evaluating the feasibility of implementing an EHR-based model within a community oncology practice.
Primary Outcome
Asses whether barriers to EHR-based SCPs and care planning have been mitigated, based on clinician survey.
Interventions
- BEHAVIORAL Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-09-11 |
| Est. Completion | 2018-03-23 |
What the finished NCT03028584 record still lists
NCT03028584 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT03028584 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03028584 about?
NCT03028584 is a clinical study titled "Survivorship Care Plans in a Community Oncology Practice". This is a two part observational study evaluating the feasibility of implementing an EHR-based model within a community oncology practice.
What is the current status of trial NCT03028584?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-09-11. Estimated completion is 2018-03-23.
What interventions are being tested in trial NCT03028584?
The interventions under investigation include: Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT03028584?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI